Last updated on April 2019

Alternatives for Reducing Tics in TS: A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents.


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Tourette's Disorder
  • Age: Between 6 - 16 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patient is 6 to 16 years of age, inclusive
  • Patient weighs at least 44 pounds (20 kg)
  • The patient's active tics are causing distress or impairment
  • Patient is able to swallow study medication whole
  • Patient is in good general health
  • Women/girls of childbearing potential whose male partners are of childbearing potential must use contraception for the duration of the study
  • Additional criteria apply, please contact the investigator for more information

Exclusion Criteria:

  • Patient has a neurologic disorder other than Tourette syndrome (TS) that could obscure the evaluation of tics.
  • Patient has a confirmed diagnosis of bipolar disorder, schizophrenia, or another psychotic disorder.
  • Patient has clinically significant depression at screening or baseline.
  • Patient has a history of suicidal intent or related behaviors within 2 years of screening.
  • Patient has a history of a previous actual, interrupted, or aborted suicide attempt.
  • Patient has a first-degree relative who has completed suicide.
  • Patient has received comprehensive behavioral intervention for tics (CBIT) for TS or cognitive behavioral therapy (CBT) for obsessive-compulsive disorder (OCD) within 4 weeks of screening.
  • Patient has an unstable or serious medical illness at screening or baseline.
  • Patient is pregnant or breastfeeding.
  • Additional criteria apply, please contact the investigator for more information.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.